Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XBI | SPDR SERIES TRUST | — | 570,000.0 | $90.2M | 48.01% | +285K | +100.1% | $158.25 | +2.6% |
| 2 | SGOV | ISHARES TR | — | 700,000.0 | $70.5M | 37.51% | — | — | $100.67 | +0.0% |
| 3 | RPRX | ROYALTY PHARMA PLC | Healthcare | 11,000.0 | $617K | 0.33% | — | — | $56.07 | +8.5% |
| 4 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 25,000.0 | $606K | 0.32% | -4K | -12.9% | $24.26 | +8.0% |
| 5 | INCY | INCYTE CORP | Healthcare | 5,300.0 | $601K | 0.32% | — | — | $113.36 | +9.7% |
| 6 | ARGX | ARGENX SE | Healthcare | 641.0 | $595K | 0.32% | — | — | $927.77 | +10.3% |
| 7 | — | DISC MEDICINE INC | — | 8,000.0 | $585K | 0.31% | — | — | $73.14 | — |
| 8 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 14,000.0 | $583K | 0.31% | — | — | $41.67 | +17.0% |
| 9 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 17,000.0 | $568K | 0.30% | -5K | -23.1% | $33.39 | -23.3% |
| 10 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 30,000.0 | $560K | 0.30% | — | — | $18.65 | -10.0% |
| 11 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 23,000.0 | $557K | 0.30% | -5K | -17.9% | $24.20 | -44.7% |
| 12 | TGTX | TG THERAPEUTICS INC | Healthcare | 10,000.0 | $549K | 0.29% | -3K | -23.1% | $54.94 | -1.8% |
| 13 | HALO | HALOZYME THERAPEUTICS INC | Healthcare | 7,000.0 | $548K | 0.29% | -1K | -12.8% | $78.27 | +34.6% |
| 14 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 6,800.0 | $539K | 0.29% | — | — | $79.29 | -23.0% |
| 15 | PHVS | PHARVARIS N V | Healthcare | 15,000.0 | $519K | 0.28% | -5K | -25.0% | $34.58 | +2.1% |
| 16 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 19,700.0 | $517K | 0.28% | — | — | $26.22 | -9.3% |
| 17 | AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | 30,000.0 | $509K | 0.27% | — | — | $16.97 | -4.0% |
| 18 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 3,000.0 | $506K | 0.27% | -848.0 | -22.0% | $168.53 | -8.6% |
| 19 | IMVT | IMMUNOVANT INC | Healthcare | 13,000.0 | $501K | 0.27% | -6K | -32.3% | $38.53 | +6.9% |
| 20 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 19,766.0 | $500K | 0.27% | — | — | $25.30 | +15.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%